Trieu Vuong 4
4 · Oncotelic Therapeutics, Inc. · Filed Nov 25, 2022
Insider Transaction Report
Form 4
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
- Purchase
Common Stock
2022-11-22$0.08/sh+70,000$5,600→ 90,438,021 total
Holdings
- 16,780,384(indirect: By Autotelic, Inc.)
Common Stock
- 6,872,529(indirect: By Spouse)
Common Stock